3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Neuroendocrine Tumors
2
Pheochromocytoma
1
Paraganglioma
1
Neuroblastoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
regorafenib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
lanreotide
1
irinotecan sucrosofate
1
PM 01183
1
Irinotecan
1
Clinical Trials, Phase II as Topic
1
Carboplatin
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Gastro-enteropancreatic neuroendocrine tumor
×
3-Iodobenzylguanidine
×
Clear all
NCT04614766
2024-04-29
SPORE-3
University of Iowa
Phase 1/2
Withdrawn